TY  - JOUR 
AU  - Costas Lago, Maria Del Carmen
AU  - Besada Pereira, Pedro
AU  - Cano Rubio, Ernesto
AU  - Terán Moldes, María del Carmen
PY  - 2019
SN  - 17568919
SN  - 17568927
UR  - http://hdl.handle.net/11093/8230
AB  - Aim: The current limitations of antiplatelet therapy promote the search for new antithrombotic agents. Here we describe novel platelet aggregation inhibitors that combine pyridazinone and coumarin scaffolds in their structure. Results: The target...
LA  - eng
PB  - Future Medicinal Chemistry
TI  - Novel compounds of hybrid structure pyridazinone–coumarin as potent inhibitors of platelet aggregation
DO  - 10.4155/fmc-2018-0373
ER  -